Compounds > pravastatin
Page last updated: 2024-08-23

pravastatin and Ventricular Fibrillation

pravastatin has been researched along with Ventricular Fibrillation in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, C; Li, L; Ma, L; Ren, Y; Wang, H; Yan, J; Yao, Y1
Ezaki, K; Fukui, A; Hara, M; Kume, O; Miyazaki, H; Nakagawa, M; Nishio, S; Saikawa, T; Takahashi, N; Teshima, Y; Thuc, LC; Yufu, K1
Chang, NC; Lee, TM; Lin, MS1

Other Studies

3 other study(ies) available for pravastatin and Ventricular Fibrillation

ArticleYear
Pravastatin attenuates cardiac dysfunction induced by lysophosphatidylcholine in isolated rat hearts.
    European journal of pharmacology, 2010, Aug-25, Volume: 640, Issue:1-3

    Topics: Animals; Creatine Kinase, MB Form; Endothelin-1; Heart; Heart Ventricles; Hemodynamics; L-Lactate Dehydrogenase; Lysophosphatidylcholines; Male; Pravastatin; Rats; Rats, Sprague-Dawley; Tachycardia; Ventricular Fibrillation

2010
Cardioprotective effects of pravastatin against lethal ventricular arrhythmias induced by reperfusion in the rat heart.
    Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:7

    Topics: Administration, Oral; Animals; Calcium; Cardiotonic Agents; Cells, Cultured; Coronary Vessels; Heart Ventricles; Ligation; Male; Membrane Potential, Mitochondrial; Models, Animal; Myocardial Reperfusion Injury; Myocytes, Cardiac; Pravastatin; Rats; Rats, Sprague-Dawley; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation

2011
Effect of pravastatin on sympathetic reinnervation in postinfarcted rats.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:6

    Topics: Animals; Blotting, Western; Cardiac Pacing, Artificial; Coronary Vessels; Disease Models, Animal; GAP-43 Protein; Glyburide; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; KATP Channels; Ligation; Male; Myocardial Infarction; Myocardium; Neurofilament Proteins; Nicorandil; Norepinephrine; Pinacidil; Polymerase Chain Reaction; Potassium Channel Blockers; Pravastatin; Rats; Rats, Wistar; RNA, Messenger; Sympathetic Nervous System; Tachycardia, Ventricular; Time Factors; Tyrosine 3-Monooxygenase; Ventricular Fibrillation; Ventricular Remodeling

2007